Serial granulocytapheresis under daily administration of rHuG-CSF: Effects on peripheral blood counts, collection efficiency, and yield

Transfusion

Volumn 41, Issue 3, 2001, Pages 390-395

  Worel, Nina ^a,b   Kurz, Martin ^a   Peters, Christina ^a   Höcker, Paul ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; BLOOD CELL COUNT; BLOOD DONOR; BONE PAIN; CLINICAL TRIAL; CYTAPHERESIS; DOSE RESPONSE; DRUG TOLERABILITY; EDEMA; GRANULOCYTE TRANSFUSION; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MYALGIA; NEUTROPENIA; PATIENT MONITORING; SKIN DEFECT; THROMBOCYTE COUNT; BLOOD SAMPLING; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; GRANULOCYTE; LEUKAPHERESIS; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STANDARD;

ADOLESCENT; ADULT; BLOOD CELL COUNT; BLOOD SPECIMEN COLLECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 0034745143     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41030390.x     Document Type: Article

References (28)

1. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: Effects of prophylactic measures
2. Infectious complication in bone marrow transplantation
3. Candidiasis in the transplant patient
4. Strategies to prevent or control infections after bone marrow transplants
5. Interventional antimicrobial therapy in febrile neutropenic patients
6. Candida infections in bone marrow transplant recipients
7. Normal granulocyte transfusion therapy: Treatment of septicemia due to gram-negative bacteria
8. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes
9. Therapeutic granulocyte transfusions in 1993
10. Clinical perspectives of granulocyte transfusions: Efficacy to date
11. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: Study of cell dose and collection technique
12. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia
13. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia
14. Granulocyte transfusions: An overlooked therapeutic modality
15. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge
16. The effect of a single or double dose of dexamethason on granulocyte collection with the continuouse flow centrifuge
17. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis
18. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor
19. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection
20. Removal of ABO-incompatible red cells from lymphocytapheresis and granulocytapheresis components before transfusion
21. Alloimmunization after granulocyte transfusions
22. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation
23. Leucocyte transfusions from rHuG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
24. Allogeneic blood stem cell transplantation: Consideration for donors
25. Blood center perspective of granulocyte transfusions: Future applications
26. A controlled study of the efficiency of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis
27. Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: A randomized, controlled epidemiology study
28. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors